Chirayu Amin
Healthcare

Chirayu Amin Net Worth

Chirayu Amin is the founder of Alembic Pharmaceuticals, one of India's oldest pharma companies. Founded by his grandfather in 1907, the company has grown to generate $478 million in revenue, with half of that coming from the domestic market. Amin is now aiming to launch 30 products in the U.S. over the next 3 years, and is supported by his three sons who work with him. He is also the brother-in-law of billionaire Harsh Mariwala.
Chirayu Amin is a member of Healthcare

Age, Biography and Wiki

Birth Place Baroda, India, India
Occupation Chairman & Managing Director of Alembic Pharmaceuticals Ltd and President of the Baroda Cricket Association.
Spouse(s) Malika Amin

💰 Net worth: $1.3 Billion (2024)

Chirayu Amin, a widely recognized figure in the healthcare industry in India, is expected to have an impressive estimated net worth of $1.3 billion in 2024. Amin has made significant contributions to the Indian healthcare sector, serving as the chairman of Alembic Pharmaceuticals Ltd., a prominent pharmaceutical company in India. Under his visionary leadership, Alembic Pharmaceuticals has experienced remarkable growth and success, garnering a strong presence in the Indian pharmaceutical market. Amin's strategic acumen and dedication to advancing healthcare in India have played a pivotal role in his achievements, ultimately leading to his substantial net worth.

2016 $1.1 Billion
2017 $1 Billion
2018 $1.11 Billion

Some Chirayu Amin images

About the author

Lisa Scholfield

As a Senior Writer at Famous Net Worth, I spearhead an exceptional team dedicated to uncovering and sharing the stories of pioneering individuals. My passion for unearthing untold narratives drives me to delve deep into the essence of each subject, bringing forth a unique blend of factual accuracy and narrative allure. In orchestrating the editorial workflow, I am deeply involved in every step—from initial research to the final touches of publishing, ensuring each biography not only informs but also engages and inspires our readership.